Y200-5290 Screening compound: 3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-1,2-oxazole-4-carboxamide

Y200-5290 Screening compound: 3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-1,2-oxazole-4-carboxamide
Y200-5290 Screening compound: 3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-1,2-oxazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-5290
3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-1,2-oxazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-5290

Molecular Formula

C19H23ClFN3O2 (C19 H23 ClFN3 O2)

Compound Name

3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-1,2-oxazole-4-carboxamide

IUPAC name

3-(2-chloro-6-fluorophenyl)-5-methyl-N-[1-(propan-2-yl)piperidin-4-yl]-12-oxazole-4-carboxamide

SMILES

CC(C)N(CC1)CCC1NC(c1c(C)onc1-c(c(F)ccc1)c1Cl)=O

InChI

InChI=1S/C19H23ClFN3O2/c1-11(2)24-9-7-13(8-10-24)22-19(25)16-12(3)26-23-18(16)17-14(20)5-4-6-15(17)21/h4-6,11,13H,7-10H2,1-3H3,(H,22,25)

InChI Key

ZQIMPSBLPZCLGV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09873502

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

379.86

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.739

Distribution Coefficient, logD

-0.195

Water Solubility, LogSw

-3.79

Polar Surface Area

50.201

Acid Dissociation Constant (pKa)

13.74

Base Dissociation Constant (pKb)

10.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.40

Y200-5290 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

CNS Targets (44014 compounds)

GABA Library (7115 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Nervous system
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y200-5290 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-5290?
Check Price and Availability of Y200-5290, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-5290 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-5290
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-5290
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-5290 available by request